Registry for pancreatic cysts at UCSF

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study establishes a comprehensive registry for patients with pancreatic cysts at UCSF. It aims to collect and analyze data on the natural history and epidemiology of pancreatic cysts, particularly focusing on small cysts that pose diagnostic challenges. By following patients over time, the study seeks to identify factors that influence cyst progression and the potential risk of malignancy, ultimately improving clinical management and decision-making regarding treatment options.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* The inclusion criteria for this study are intentionally broad. Eligible patients for prospective enrollment will include
* Adults ≥ 30 years of age
* Have a radiographic or endoscopic diagnosis of at least one pancreatic cysts regardless of treatment status,
* No history of pancreatic cancer,
* Can speak and read English,
* Have access to a computer or mobile device (\~95% of U.S. population); and
* Are able to complete an electronic informed consent.

Exclusion Criteria:

* Patients who don't speak English,
* Don't have access to a computer or mobile device; or
* Patients who have a cancer diagnosis.

Where it's running

• University of California, San Francisco
  San Francisco, California, United States Recruiting

Study contacts

• Principal investigator: Kimberly S Kirkwood, MD — University of California, San Francisco
• Study coordinator: Charysa Santos, BS
• Email: Charysa.Santos@ucsf.edu
• Phone: 415-514-6914

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• AI-based early detection of pancreatic cancer using routine CT scans

  This study is testing an AI system that uses regular CT scans to see if it can help find pancreatic cancer early in people who are at high risk.

  Recruiting at 3 sites Changhai Hospital · Shanghai, Shanghai Municipality and 2 other locations · NCT06638866

• Early detection of pancreatic cancer using exosome-based biomarkers

  This study is testing a new way to find pancreatic cancer early by looking at tiny particles in the blood that carry specific markers.

  Recruiting at 11 sites City of Hope Medical Center · Phoenix, Arizona and 12 other locations · NCT06388967

• Using technology to improve care for pancreatic cancer patients

  This study is trying to see if sharing patient data among hospitals can help improve care and outcomes for people with pancreatic cancer.

  Recruiting UMC Utrecht · Utrecht · NCT06055010

• T cell therapy targeting KRAS G12V mutation for advanced pancreatic cancer

  This study is testing a new T cell therapy that uses patients' own immune cells to target a specific mutation in advanced pancreatic cancer to see if it can help them fight the disease.

  Recruiting Phase 1/2 Changhai Hospital · Shanghai · NCT04146298

• Developing a blood test for early diagnosis of pancreatic cancer

  This study is trying to develop a simple blood test to help find pancreatic cancer early and track how well treatments are working for patients.

  Recruiting at 8 sites Memorial Sloan Kettering Cancer Center · Middletown, New Jersey and 12 other locations · NCT03334708

• Using contrast-enhanced ultrasound to check for local pancreatic cancer recurrence after surgery

  This pilot test uses contrast-enhanced ultrasound to see if it can help detect return of pancreatic cancer after surgery in patients being watched with CT scans.

  Recruiting Thomas Jefferson University · Philadelphia, Pennsylvania · NCT07910383

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.